| Source | Evidence on protein | Close homologs |
|---|---|---|
| Cuervo et al. | no | yes: 0 |
| Hassani et al. | no | yes: 0 |
| Forrest at al. (metacyclic) | no | yes: 0 |
| Forrest at al. (procyclic) | no | yes: 0 |
| Silverman et al. | no | yes: 0 |
| Pissara et al. | no | yes: 0 |
| Source | Evidence on protein | Close homologs |
|---|---|---|
| Pires et al. | no | yes: 0 |
| Source | Evidence on protein | Close homologs |
|---|---|---|
| Silverman et al. | no | yes: 0 |
| Source | Evidence on protein | Close homologs |
|---|---|---|
| Jamdhade et al. | no | yes: 0 |
| Source | Evidence on protein | Close homologs |
|---|---|---|
| DeepLoc | ||
| SignalP6 | no | yes: 0, no: 10 |
| NetGPI | no | yes: 0, no: 10 |
Related structures:
AlphaFold database: A4HQG5
| Leishmania | From | To | Domain/Motif | Score |
|---|---|---|---|---|
| CLV_NRD_NRD_1 | 102 | 104 | PF00675 | 0.691 |
| CLV_NRD_NRD_1 | 148 | 150 | PF00675 | 0.669 |
| CLV_NRD_NRD_1 | 169 | 171 | PF00675 | 0.584 |
| CLV_PCSK_KEX2_1 | 148 | 150 | PF00082 | 0.669 |
| CLV_PCSK_SKI1_1 | 175 | 179 | PF00082 | 0.609 |
| CLV_PCSK_SKI1_1 | 184 | 188 | PF00082 | 0.525 |
| CLV_PCSK_SKI1_1 | 191 | 195 | PF00082 | 0.449 |
| DOC_MAPK_gen_1 | 148 | 154 | PF00069 | 0.642 |
| DOC_MAPK_gen_1 | 90 | 98 | PF00069 | 0.626 |
| DOC_PP4_FxxP_1 | 154 | 157 | PF00568 | 0.572 |
| DOC_PP4_FxxP_1 | 76 | 79 | PF00568 | 0.677 |
| DOC_USP7_MATH_1 | 22 | 26 | PF00917 | 0.704 |
| DOC_USP7_MATH_1 | 79 | 83 | PF00917 | 0.680 |
| LIG_14-3-3_CanoR_1 | 103 | 109 | PF00244 | 0.660 |
| LIG_14-3-3_CanoR_1 | 122 | 126 | PF00244 | 0.626 |
| LIG_14-3-3_CanoR_1 | 184 | 192 | PF00244 | 0.608 |
| LIG_14-3-3_CanoR_1 | 23 | 27 | PF00244 | 0.597 |
| LIG_14-3-3_CanoR_1 | 71 | 77 | PF00244 | 0.566 |
| LIG_Actin_WH2_2 | 55 | 73 | PF00022 | 0.638 |
| LIG_APCC_ABBA_1 | 56 | 61 | PF00400 | 0.594 |
| LIG_APCC_ABBAyCdc20_2 | 55 | 61 | PF00400 | 0.574 |
| LIG_BH_BH3_1 | 35 | 51 | PF00452 | 0.631 |
| LIG_BRCT_BRCA1_1 | 182 | 186 | PF00533 | 0.630 |
| LIG_deltaCOP1_diTrp_1 | 172 | 178 | PF00928 | 0.571 |
| LIG_FHA_1 | 112 | 118 | PF00498 | 0.610 |
| LIG_FHA_1 | 140 | 146 | PF00498 | 0.599 |
| LIG_LIR_Apic_2 | 151 | 157 | PF02991 | 0.579 |
| LIG_LIR_Apic_2 | 75 | 79 | PF02991 | 0.678 |
| LIG_LIR_Gen_1 | 94 | 99 | PF02991 | 0.565 |
| LIG_LIR_Nem_3 | 94 | 98 | PF02991 | 0.582 |
| LIG_OCRL_FandH_1 | 88 | 100 | PF00620 | 0.622 |
| LIG_SH2_STAP1 | 74 | 78 | PF00017 | 0.679 |
| LIG_SH2_STAT3 | 106 | 109 | PF00017 | 0.587 |
| LIG_SH2_STAT5 | 106 | 109 | PF00017 | 0.587 |
| LIG_SH2_STAT5 | 74 | 77 | PF00017 | 0.621 |
| LIG_SUMO_SIM_anti_2 | 28 | 35 | PF11976 | 0.425 |
| LIG_SUMO_SIM_par_1 | 28 | 35 | PF11976 | 0.425 |
| LIG_UBA3_1 | 165 | 171 | PF00899 | 0.607 |
| LIG_WRC_WIRS_1 | 73 | 78 | PF05994 | 0.564 |
| MOD_Cter_Amidation | 101 | 104 | PF01082 | 0.694 |
| MOD_GlcNHglycan | 5 | 8 | PF01048 | 0.625 |
| MOD_GSK3_1 | 176 | 183 | PF00069 | 0.638 |
| MOD_NEK2_1 | 121 | 126 | PF00069 | 0.697 |
| MOD_NEK2_1 | 31 | 36 | PF00069 | 0.623 |
| MOD_NMyristoyl | 1 | 7 | PF02799 | 0.570 |
| MOD_PKA_2 | 121 | 127 | PF00069 | 0.599 |
| MOD_PKA_2 | 137 | 143 | PF00069 | 0.677 |
| MOD_PKA_2 | 22 | 28 | PF00069 | 0.579 |
| MOD_Plk_4 | 72 | 78 | PF00069 | 0.582 |
| MOD_SUMO_rev_2 | 47 | 57 | PF00179 | 0.662 |
| TRG_ER_diArg_1 | 189 | 192 | PF00400 | 0.605 |
| Protein | Taxonomy | Sequence identity | Coverage |
|---|---|---|---|
| A0A0N1HYZ7 | Leptomonas seymouri | 86% | 100% |
| A0A0S4IQL1 | Bodo saltans | 62% | 100% |
| A0A1X0NLH3 | Trypanosomatidae | 69% | 100% |
| A0A3R7MH65 | Trypanosoma rangeli | 68% | 100% |
| A0A3S7XC64 | Leishmania donovani | 93% | 100% |
| A4ICA1 | Leishmania infantum | 93% | 100% |
| D0A3L6 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 70% | 100% |
| E9AU81 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 91% | 100% |
| Q4Q0B3 | Leishmania major | 92% | 100% |